Swiss Life Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.21M Buy
16,999
+5,349
+46% +$1.42M 0.03% 361
2026
Q1
$1.28M Buy
11,650
+2,672
+30% +$381K 0.01% 615
2025
Q4
$1.49M Buy
8,978
+2,926
+48% +$490K 0.01% 592
2025
Q3
$1.18M Buy
6,052
+2,668
+79% +$439K 0.01% 615
2025
Q2
$306K Buy
+3,384
New +$267K ﹤0.01% 718

Other funds holding ALAB

Swiss Life Asset Management's ALAB Position: Q2 2026 in Review

Swiss Life Asset Management increased its Astera Labs (ALAB) stake by 46% in Q2 2026, buying an estimated $1.42M and bringing the position to 16,999 shares worth $8.21M. The position accounts for 0.03% of the portfolio, ranked #361.

Swiss Life Asset Management first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 661 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Swiss Life Asset Management held 16,999 shares of Astera Labs worth $8.21M as of Q2 2026.
  • Swiss Life Asset Management bought 5,349 Astera Labs shares in Q2 2026, an estimated $1.42M.
  • Astera Labs made up 0.03% of Swiss Life Asset Management's portfolio in Q2 2026, its #361 holding.
  • Swiss Life Asset Management first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 661 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.